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Abstract
Segregation of two axial vessels, the dorsal aorta and caudal vein, is one of the earliest patterning
events occur during development of vasculature. Despite the importance of this process and recent
advances in our understanding on vascular patterning during development, molecular mechanisms
that coordinate the segregation of axial vessels remain largely elusive. In this report, we find that
Vascular Endothelial Growth Factor-A (Vegf-A) signaling regulates the segregation of dorsal
aorta and axial vein during development. Inhibition of Vegf-A pathway components including
ligand Vegf-A and its cognate receptor Kdrl, caused failure in segregation of axial vessels in
zebrafish embryos. Similarly, chemical inhibition of Mitogen-activated protein kinase kinase
(Map2k1)/Extracellular-signal-regulated kinases (Erk) and Phosphatidylinositol 3-kinases (PI3K),
which are downstream effectors of Vegf-A signaling pathway, led to the fusion of two axial
vessels. Moreover, we find that restoring Erk activity by over-expression of constitutively active
MEK in embryos with a reduced level of Vegf-A signaling can rescue the defects in axial vessel
segregation. Taken together, our data show that segregation of axial vessels requires the function
of Vegf-A signaling, and Erk may function as the major downstream effector in this process.
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1. INTRODUCTION
The vascular network, which provides the essential functions of delivering oxygen and
removing metabolic waste products, is one of the first organs to emerge in embryos. In
vertebrates, the vascular system is formed by two distinct processes, vasculogenesis, de
novo formation of blood vessels, and angiogenesis, the formation of new blood vessels from
preexisting vessels. During development, endothelial cells, the innermost lining of the
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vascular network, form transient aggregates known as the vascular cord in the midline [1,2].
Endothelial cells within the vascular cord start to express arterial and venous specific
markers as early as E11.5 in mouse [3], and as early as 18 hours post-fertilization (hpf) in
zebrafish [1,4], preceding the emergence of morphologically distinct arteries and veins [5].
Subsequently, developing vasculature acquires the stereotypic hierarchy; arteries and veins
are physically separated and only connected by the capillaries. Failure to segregate arteries
and veins results in ectopic shunts connecting these two types of vessels, a pathological
condition known as arteriovenous malformation (AVM) [6]. While the etiology of AVM
remains largely unknown, recent advances start to unravel the molecular and cellular
mechanisms that underlie the sorting of arterial and venous endothelial cells. Attenuation of
several genes has shown to cause failure in segregation of axial vessels in vertebrates. For
instance, mutation in Dll4 in mice causes improper segregation of the dorsal aorta and the
cardinal vein, creating arteriovenous shunts [7,8]. Similarly, simultaneous reduction of sox7
and sox18 genes resulted in improper segregation of the dorsal aorta and the cardinal vein
[9,10,11]. In all cases, both differentiation of arterial/venous endothelial cells and the
segregation of the axial vessels were affected, suggesting that these two events are tightly
linked developmental processes.
Recent studies have shown that arterial and venous endothelial cells respond differently to
various signaling molecules, which might be the main driving force for the segregation of
arteries and veins during development. For instance, Vascular Endothelial Growth Factor-A
(Vegf-A) and Vascular Endothelial Growth Factor-C (Vegf-C) signaling preferentially
activates dorsal migration of arterial endothelial cells and ventral migration of venous
endothelial cells respectively, within the vascular cord, therefore, synergistically promoting
the segregation of axial vessels in zebrafish embryos [2]. In addition, the repulsive
interaction between EphrinB2 and EphB4 has been shown to be critical in regulating the
segregation of arterial endothelial cells from the venous endothelial cells in developing
mouse embryo. The dorsal aorta in mice lacking EphrinB2 or EphB4 contained venous
endothelial cells, leading to the enlarged dorsal aorta at the expense of the cardinal vein [12].
Later in development, we have recently demonstrated that arterial and venous endothelial
cells exhibit different responses to Vegf-A and Bone Morphogenetic Protein (Bmp)
signaling [13]. While Bmp signaling induces angiogenesis within venous endothelial cells,
arterial endothelial cells remain unaffected. Conversely, Vegf-A signaling preferentially
facilitates angiogenesis within arterial endothelial cells without activating venous
endothelial cells. Collectively, these reports indicate distinct molecular nature of arterial and
venous endothelial cells. However, it is unclear how differences in molecular characteristics
of arterial and venous endothelial cells contribute to the segregation of axial vessels.
Moreover, it is unknown which signaling pathways regulate the segregation of axial vessels
during development. Considering its importance during vascular development, it is likely
that VEGF-A signaling may provide a pivotal function in this process.
In this study, we used zebrafish as a model system to investigate the role of Vegf-A
signaling during the segregation of axial vessels. We find that reduction in Vegf-A signaling
activity led to a failure in the segregation of arteries and veins. Moreover, we find that
inhibition of Erk, which are known to function downstream of Vegf-A signaling pathway [4]
yield similar defects in developing zebrafish, while activation of Erk in embryos with a
reduced level of Vegf-A activity can restore the segregation defects, indicating that
activation of Erk by Vegf-A signaling is essential for the proper segregation of axial vessels.
Taken together, our data demonstrate the critical role of Vegf-A signaling during the
segregation of axial vessels.
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2. METHODS & MATERIALS
2.1. Zebrafish husbandry and positional cloning
Zebrafish (Danio rerio) embryos and adults were raised and maintained as previously
described under IACUC guidelines [14].
2.2. Microinjection and chemical treatment
Morpholinos (MO) (Gene Tools, LLC) were injected into 1-cell-stage Tg(kdrl:EGFP)





ATTAGCATAGGGAACTTACTTTCG-3′ [17]. For chemical treatment, embryos were
treated from the 10 somite stage to 30 hours post fertilization (hpf) unless noted otherwise,
and fixed overnight in 4% paraformaldehyde (PFA). To transiently express constitutively
active MEK (CA-MEK) [18] in endothelial cells, CA-MEK was subcloned into the Gateway
middle entry vector and recombined into kdrl promoter containing vector. The resulting
construct allows kdrl promoter regulated, transient expression of CA-MEK in a subset of
endothelial cells in injected embryos.
2.3. Immunohistochemistry, western blot, and in situ hybridization
Immunohistochemistry and in situ hybridization were performed as previously described [1].
Anti-β-catenin antibody (1:150, BD Biosciences) was used to show cell boundaries.
2.4. Phenotypic analyses
30hpf zebrafish embryos were analyzed by fluorescent stereomicroscope to examine the
vascular morphology. For those appear to contain a single axial vessels, transverse sections
from 10th somite to 18th somite of 30hpf zebrafish embryos were analyzed by confocal
microscopy. Minimum of ten sections per embryos were analyzed. If the embryo had more
than seven sections with single axial vessels, it was counted as ‘embryos with a single axial
vessel’.
2.5. Quantitative RT-PCR
Quantitative RT-PCR was performed as previously reported [19]. The trunk region (above
the yolk extension) of the embryos was dissected and RNA was extracted, and pre-tested
qRT-PCR primers (Applied biosystems) were used to detect the gene expression.
3. RESULTS & DISCUSSION
To examine the function of Vegf-A signaling during segregation of axial vessels, we
attenuated the function of well characterized components of Vegf-A signaling in
Tg(kdrl:EGFP)s843 embryos [1]. Blocking Vegf-A signaling by injecting morpholino (MO)
against vegf-aa or plcγ caused failure in segregation of axial vessels (Figure 1A to C),
indicating that Vegf-A signaling plays an important role in the segregation of axial vessels.
In zebrafish genome, two functional orthologs of Vascular Endothelial Growth Factor
Receptor 2 (VEGFR2/KDR), vegfr2/kdr and vegfr4/kdrl are present [20]. Previously, it has
been shown that the function of Kdr appears to be largely dispensable for the specification
of arterial endothelial cells, although Kdrl and Kdr might function redundantly to promote
segmental artery formation [21]. Therefore, it is plausible that Kdrl and Kdr may have a
distinct role in transducing the activity of Vegf-A signaling during axial vessel segregation
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in zebrafish. To examine this possibility, we selectively inhibited Kdrl or Kdr during
development, and analyze the resulting vascular phenotype (Figure 2).
While embryos injected with kdrl MO contained only a single axial vessel, those injected
with kdr MO injected embryos had a distinct dorsal aorta and axial vein, suggesting that the
function of Kdr may be dispensable for the segregation of axial vessels (Figure 2B and C).
Furthermore, the severity and penetrance of defects on axial vessel segregation in embryos
co-injected with kdrl and kdr MO were comparable to those of embryos injected with kdrl
MO alone, suggesting that the contribution of Kdr to the segregation of axial vessels is
likely to be minor.
Interestingly, blocking either Kdrl or Kdr function led a significant reduction in the
expression level of arterial and venous specific genes, indicating that both Vegfr2/KDR
orthologs are required to promote or maintain the expression of differentiated endothelial
cell markers (Figure 2D). Taken together, it seems that both Kdr and Kdrl are required to
maintain and/or initiate differentiation of endothelial cells, while Kdrl appears to be the
main Vegf-A receptor during segregation of axial vessels.
One of the main downstream effector of Vegf-A signaling is Protein Kinase C (PKC), which
is activated by diacylglycerol (DAG) [22]. It has been shown that inhibition of PKC by
chemical antagonists blocks the pro-angiogenic effects of Vegf-A signaling. To test whether
PKC is also involved in transducing Vegf-A signaling during segregation of axial vessels,
we attenuated the level of PKC activity. 14hpf wild-type zebrafish embryos were treated
with 60μM Bisindolylmaleimide, a known antagonist of PKC, for 16 hours [23]. As a
positive control, SU5416, a well characterized chemical antagonist of VEGFR2, was used.
In embryos treated with SU5416, the axial vessels failed to segregate as expected (n=20)
(Figure 3A and E). Similarly, we find that failure in segregation of axial vessels failed in
embryos with reduced PKC activity (n=75) (Figure 3B and E), indicating that PKC is an
essential mediator for Vegf-A signaling during segregation of axial vessels.
Two prominent downstream effectors of PKC activity in the Vegf-A signaling cascade is
Map2k1/Erk and Akt/PI3K, which elicit a variety of cellular responses including increased
vascular permeability, elevated eNOS production, and initiation of Vegf-A target genes [24].
To determine the function of these two signaling pathways in transducing Vegf-A signaling
during the segregation of axial vessels, we also attenuated the activity of Map2k1/Erk or
Akt/PI3K, and examined the resulting vascular phenotype.
When embryos were treated with 25μM U0126, a chemical antagonist of Map2k1/Erk [25],
from 14 to 30hpf, a significant portion of the embryos had a single axial vessel with
impaired circulation, which was reminiscent of the phenotype of embryos with
compromised Vegf-A signaling (n=105), suggesting that the Map2k1/Erk activity is required
to mediate Vegf-A signaling during the segregation of axial vessels (Figure 3C and E).
Similarly, to investigate the contribution of Akt/PI3K in antagonizes Map2k1/Erk in a
similar manner to modulate Vegf-A signaling during the segregation of axial vessels, we
treated embryos from 14 to 30hpf with 30μM LY294002, a chemical antagonist that inhibits
phosphorylation of Akt therefore attenuating PI3K activity (n=98) [26]. Inhibition of PI3K
activity at this stage caused vascular defects comparable to Map2k1/Erk inhibition (Figure
3D and E). Approximately 70 percent of the embryos treated with LY294002 displayed a
single axial vessel (Figure 3E). Taken together, our data indicate that effects of Vegf-A
signaling during the segregation of the axial vessels require the activity of PKC, Erk, and
PI3K.
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To examine whether activation of these downstream effectors is sufficient to initiate
segregation of axial vessels in embryos with a reduced level of Vegf-A signaling, we
utilized chemical genetics approach. To test whether the activation of PKC is sufficient to
bypass the requirement of Vegf-A signaling, kdrl MO injected embryos were incubated with
16μM 12-O-tetradecanoylphorbol-13-acetate (TPA) [27], a chemical agonist of PKC from
14 to 30hpf. As a positive control, we used GS4012, a chemical agonist of Vegf-A signaling.
While kdrl MO injected embryos incubated with DMSO (empty vehicle) contained a single
axial vessel (n=40, Figure 4A and B), 77 percent of kdrl MO injected embryos treated with
GS4012, and 86 percent of kdrl MO injected embryos incubated with TPA had a clearly
separate dorsal aorta and axial vein (n=55 for GS4012, and n=42 for TPA, Figure 4A and
B). Therefore, activation of PKC is sufficient to alleviate defects on the segregation of axial
vessels caused by reduced Vegf-A signaling.
To further examine the function of Map2k1/Erk in the segregation of axial vessels,
constitutively active MEK (CA-MEK) was selectively expressed in endothelial cells in kdrl
MO injected embryos [18] (Figure 4C and D). Since MEK induces activation of Map2k1/
Erk, ectopic expression of CA-MEK in endothelial cells should alleviate the phenotype of
kdrl MO injected embryos. While less than two percent of embryos co-injected with a vector
encoding Blue Fluorescent Protein (BFP) and kdrl MO contained two axial vessels at 28hpf
(Figure 4E), a significant portion (38%) of embryos co-injected with the CA-MEK construct
and kdrl MO had clearly distinguishable axial vessels (Figure 4E), suggesting that Map2k1/
Erk activity is critical for the segregation of the axial vessels, but dispensable for the
maintenance of the arterial or venous specific gene expression downstream of Vegfr
signaling.
4. CONCLUSION
In this report, we investigated the function of Vegf-A signaling in the segregation of axial
vessels during vertebrate development. We find that Vegf-A signaling is indispensable for
the proper segregation of axial vessels. Among two zebrafish orthologs of VEGFR3/KDR,
we find that the function of Kdr appears to be dispensable for the segregation of axial
vessels. Despite drastically reduced expression of arterial or venous markers, a distinct
dorsal aorta and axial vein were formed in kdr MO injected embryos. Therefore, it appears
that Kdrl is the main receptor to mediate Vegf-A signaling during the segregation of axial
vessels. During the segregation of axial vessels, Vegf-A signaling appears to promote
activity of Erk and PI3K, since inhibition of either Erk or PI3K activity caused similar
vascular defects as in embryos with compromised Vegf-A signaling. Moreover, activation of
Erk signaling in Vegf-A signaling deficient embryos restored the defects in axial vessel
segregation, indicating that Erk signaling may play a key role in mediating Vegf-A signaling
activity in this process.
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1. VEGF-A signaling regulates the segregation of axial vessels.
2. VEGF-A signaling is mediated by PKC and ERK in this process.
3. Ectopic activation of ERK is sufficient to rescue defects in vessel segregation.
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Figure 1. Attenuation of Vegf-A signaling components causes defects in axial vessel segregation
as observed in kdrls828 mutants
Transverse sections taken at the level of the 14th somite were analyzed by confocal
microscopy. 36hpf wild-type (A), vegf-aa MO injected (B), and plcγ MO injected (C)
embryos in Tg(kdrl:EGFP)s843 background. Endothelial cells are visualized by the
expression of EGFP transgene (green), cell boundaries are shown by Anti-β-catenin staining
(red). White arrows in panels B and C point to the single axial vessel. Abbreviations: DA,
dorsal aorta, CV, caudal vein.
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Figure 2. Kdrl functions as the main receptor for Vegf-A signaling during the segregation of
axial vessels
Bright field micrographs (top row), epifluorescence micrographs (middle row), and confocal
images of a transverse section at the 14th somite level (bottom row) of 36hpf embryos
injected with control MO (A), kdrl MO (B), or kdr MO (C) in Tg(kdrl:EGFP)s843
background. Endothelial cells are visualized by the expression of EGFP transgene (green),
cell boundaries are shown by Anti-β-catenin staining (red). White arrowhead in panel B
points to the single axial vessel. (D) Quantitative RT-PCR of endothelial specific genes in
36hpf MO injected embryos. Attenuation of either kdrl or kdr significantly reduced the
expression of arterial and venous marker expression. Abbreviations: DA, dorsal aorta, CV,
caudal vein.
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Figure 3. Attenuation of Vegf-A downstream effectors caused defects in segregation of axial
vessels
Transverse sections taken at the level of the 14th somite were analyzed by confocal
microscopy. 36hpf Tg(kdrl:EGFP)s843 embryos treated with 1μM SU5416 (A), 60μM
Bisindolylmaleimide, a chemical antagonist of PKC (B), 25μM U0126 (C), or 30μM
LY294002 (D). (E) Quantification of chemical treatments. Compared to DMSO treated
embryos, the percentage of embryos with a single axial vessel was significantly increased in
embryos treated with SU5416, Bisindolylmaleimide, U0126, or LY294002 (P<0.001).
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Figure 4. Activation of PKC or Erk activity can rescue the defects in segregation of axial vessels
in embryos with compromised Vegf-A signaling
Transverse sections taken at the level of the 14th somite were analyzed by confocal
microscopy. 36hpf Tg(kdrl:EGFP)s843 embryos treated with DMSO (left), 7.5μg/ml
GS4012 (middle), and 16μM 12-O-tetradecanoylphorbol-13-acetate (right). (B) Treatment
with 16μM 12-O-tetradecanoylphorbol-13-acetate restored the defects in segregation of
axial vessels better than GS4012, a positive control. (C) Transverse sections taken at the
level of the 14th somite from kdrl MO injected embryos, co-injected with either vector
containing Blue Fluorescent Protein (BFP) or constitutively active MEK (CA-MEK). (D)
PCR confirmation showing the validity of kdrl MO (left) and expression of CA-MEK
construct (right). (E) The defect in axial vessel segregation in kdrl MO injected embryos
was substantially rescued by ectopic activation of MEK, which can increase the level of Erk
activity. Abbreviations: DA, dorsal aorta, CV, caudal vein.
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